250 related articles for article (PubMed ID: 22766646)
1. A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings.
Savard P; Perl TM
Curr Opin Infect Dis; 2012 Aug; 25(4):371-7. PubMed ID: 22766646
[TBL] [Abstract][Full Text] [Related]
2. Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals.
Williamson DA; Sidjabat HE; Freeman JT; Roberts SA; Silvey A; Woodhouse R; Mowat E; Dyet K; Paterson DL; Blackmore T; Burns A; Heffernan H
Int J Antimicrob Agents; 2012 Jun; 39(6):529-33. PubMed ID: 22526013
[TBL] [Abstract][Full Text] [Related]
3. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
[TBL] [Abstract][Full Text] [Related]
4. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
[TBL] [Abstract][Full Text] [Related]
5. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.
Gupta N; Limbago BM; Patel JB; Kallen AJ
Clin Infect Dis; 2011 Jul; 53(1):60-7. PubMed ID: 21653305
[TBL] [Abstract][Full Text] [Related]
6. Resistance in gram-negative bacteria: enterobacteriaceae.
Paterson DL
Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe.
Cantón R; Novais A; Valverde A; Machado E; Peixe L; Baquero F; Coque TM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():144-53. PubMed ID: 18154538
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of extended-spectrum beta-lactamases.
Rodríguez-Baño J; Pascual A
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):671-83. PubMed ID: 18847405
[TBL] [Abstract][Full Text] [Related]
9. [Carbapenemase-producing enterobacteriae: epidemiology, strategies to control their spread and issues].
Lepelletier D; Batard E; Berthelot P; Zahar JR; Lucet JC; Fournier S; Jarlier V; Grandbastien B
Rev Med Interne; 2015 Jul; 36(7):474-9. PubMed ID: 25600328
[TBL] [Abstract][Full Text] [Related]
10. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples.
Wieler LH; Ewers C; Guenther S; Walther B; Lübke-Becker A
Int J Med Microbiol; 2011 Dec; 301(8):635-41. PubMed ID: 22000738
[TBL] [Abstract][Full Text] [Related]
11. The threat of carbapenem-resistant Enterobacteriaceae in Lebanon: an update on the regional and local epidemiology.
El-Herte RI; Kanj SS; Matar GM; Araj GF
J Infect Public Health; 2012 Jun; 5(3):233-43. PubMed ID: 22632597
[TBL] [Abstract][Full Text] [Related]
12. How to stem the tide of carbapenemase-producing enterobacteriaceae?: proactive versus reactive strategies.
Bilavsky E; Schwaber MJ; Carmeli Y
Curr Opin Infect Dis; 2010 Aug; 23(4):327-31. PubMed ID: 20581673
[TBL] [Abstract][Full Text] [Related]
13. Multiresistant Enterobacteriaceae: new threat of an old problem.
Pitout JD
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):657-69. PubMed ID: 18847404
[TBL] [Abstract][Full Text] [Related]
14. A review of multidrug-resistant Enterobacteriaceae.
Pereira EC; Shaw KM; Vagnone PM; Harper J; Lynfield R
Minn Med; 2011 Oct; 94(10):44-8. PubMed ID: 23256284
[TBL] [Abstract][Full Text] [Related]
15. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.
Carmeli Y; Akova M; Cornaglia G; Daikos GL; Garau J; Harbarth S; Rossolini GM; Souli M; Giamarellou H
Clin Microbiol Infect; 2010 Feb; 16(2):102-11. PubMed ID: 20085604
[TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
[TBL] [Abstract][Full Text] [Related]
17. Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases).
Lynch JP; Clark NM; Zhanel GG
Expert Opin Pharmacother; 2013 Feb; 14(2):199-210. PubMed ID: 23321047
[TBL] [Abstract][Full Text] [Related]
18. [Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria].
Bayraktar B; Toksoy B; Bulut E
Mikrobiyol Bul; 2010 Apr; 44(2):187-96. PubMed ID: 20549952
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiology and clinical implications of carbapenemase-producing bacteria in Switzerland].
Abbas M; Cherkaoui A; Fankhauser C; Schrenzel J; Harbarth S
Rev Med Suisse; 2012 Apr; 8(338):882-4, 886-9. PubMed ID: 22611624
[TBL] [Abstract][Full Text] [Related]
20. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
Asensio Á; Cantero M; Shaw E; Vergara-López S
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():61-6. PubMed ID: 25542054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
